CITTERIO, PAOLA MARIA
 Distribuzione geografica
Continente #
EU - Europa 935
NA - Nord America 611
AS - Asia 270
SA - Sud America 7
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.829
Nazione #
US - Stati Uniti d'America 582
GB - Regno Unito 435
SE - Svezia 139
CN - Cina 103
DE - Germania 94
IT - Italia 67
UA - Ucraina 59
SG - Singapore 47
TR - Turchia 42
KR - Corea 34
IN - India 30
CA - Canada 29
IE - Irlanda 28
FR - Francia 26
EU - Europa 23
RU - Federazione Russa 22
NL - Olanda 18
FI - Finlandia 17
BE - Belgio 9
GR - Grecia 8
RO - Romania 8
CO - Colombia 7
HK - Hong Kong 5
AU - Australia 3
CH - Svizzera 2
EG - Egitto 2
ES - Italia 2
ID - Indonesia 2
JP - Giappone 2
PH - Filippine 2
IL - Israele 1
MY - Malesia 1
PL - Polonia 1
VN - Vietnam 1
Totale 1.851
Città #
Southend 404
Chandler 107
Wilmington 38
Jacksonville 36
Princeton 34
Woodbridge 32
Seattle 29
Beijing 28
Dublin 28
Ann Arbor 26
Milan 25
Redmond 25
Nanjing 21
Singapore 21
Toronto 20
Dearborn 17
Kent 17
Boardman 16
Sakarya 16
Somerville 16
Ashburn 15
Bengaluru 14
Des Moines 13
Fairfield 13
Roxbury 11
Auburn Hills 9
Brussels 9
Mumbai 9
Serra 9
Andover 8
Athens 8
Mountain View 8
Bogotá 7
Grafing 7
Nürnberg 7
Ottawa 7
Fremont 6
Palaiseau 6
Los Angeles 5
Cambridge 4
Chicago 4
Hebei 4
Hong Kong 4
Houston 4
Nanchang 4
Shanghai 4
Shenyang 4
Bitonto 3
Changsha 3
Hefei 3
Jinan 3
Margão 3
Tianjin 3
Al Mansurah 2
Baotou 2
Brescia 2
Haikou 2
Hangzhou 2
Jakarta 2
Kiez 2
Ningbo 2
Phoenix 2
Redwood City 2
San Diego 2
Verona 2
Zhengzhou 2
Anqing 1
Arese 1
Bergamo 1
Berlin 1
Brentwood 1
Brisbane 1
Como 1
Eitensheim 1
Falls Church 1
Fuzhou 1
Guangzhou 1
Hanoi 1
Helsinki 1
Hilliard 1
Jiaxing 1
Kiev 1
Kunming 1
Lane Cove 1
Lanzhou 1
Lecce 1
London 1
Montreal 1
Niagara Falls 1
Norwalk 1
Petaling Jaya 1
Preston 1
Pskov 1
Roseville 1
Seoul 1
Shaoxing 1
Stockholm 1
Sydney 1
Taizhou 1
Tel Aviv 1
Totale 1.237
Nome #
Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects 192
Vpr and HIV-1 disease progression : R77Q mutation is associated with long-term control of HIV-1 infection in different groups of patients 171
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection : in vitro studies of mixed virus infections 157
Analysis of protease inhibitor combinations in vitro : activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates 151
Unusual codon 69 insertions : influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility 146
Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine 143
Susceptibility to PNU-140690 (Tipranavir) of human immunodeficiency virus type 1 isolates derived from patients with multidrug resistance to other protease inhibitors 139
In vitro inhibition of HIV-1 by Met-SDF-1beta alone or in combination with antiretroviral drugs 116
In vitro evolution of the human immunodeficiency virus type 1 gag-protease region and maintenance of reverse transcriptase resistance following prolonged drug exposure 101
Evidence of stavudine-related phenotypic resistance among zidovudine-pretreated HIV-1-infected subjects receiving a therapeutic regimen of stavudine plus lamivudine 95
Effective inhibition of HIV-1 isolated from patients with acute primary HIV-1 infection by aminooxypentane-RANTES 86
Rapid onset of M184V mutation and phenotypic resistance to stavudine in zidovudine pre-treated HIV-1-infected individuals receiving the therapeutic regimens zidovudine plus lamivudine or stavudine plus lamivudine 84
Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure 81
In vitro effects of continuous pressure with zidovudine (ZDV) and lamivudine on a ZDV-resistant HIV-1 isolate 81
Lack of in vitro anti-gp160 antibody production is a correlate of nonprogression among HIV type 1-infected individuals 79
Entry and fusion inhibitors of HIV 76
In vitro inhibition of HIV-1 by Met-SDF-1β alone or in combination with antiretroviral drugs 49
Totale 1.947
Categoria #
all - tutte 4.731
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.731


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020205 28 9 20 9 17 16 25 11 21 30 15 4
2020/2021284 12 15 32 1 25 12 19 24 47 13 74 10
2021/2022191 22 19 4 5 2 5 10 14 28 30 7 45
2022/2023286 23 32 29 49 29 64 0 23 24 0 10 3
2023/2024117 8 11 1 2 35 8 1 5 0 18 13 15
2024/202510 10 0 0 0 0 0 0 0 0 0 0 0
Totale 1.947